Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
Clinical trial NCT05098470 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05098470
- Sponsor
- University of Alabama at Birmingham
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-07
- Primary completion
- 2025-07-29
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.